NMDA Antagonists as Neurotherapeutic Drugs, Psychotogens, Neurotoxins, and Research Tools for Studying Schizophrenia

Neuropsychopharmacology - United Kingdom
doi 10.1016/0893-133x(95)00079-s
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Analgesic Antipyretic Drugs as Antagonists of Bradykinin

British Journal of Pharmacology and Chemotherapy
1960English

Amino-Alkyl-Cyclohexanes as a Novel Class of Uncompetitive NMDA Receptor Antagonists

Current Pharmaceutical Design
Drug DiscoveryPharmacology
2002English

Genetic Tools for Studying Capnocytophaga Canimorsus

Applied and Environmental Microbiology
Applied MicrobiologyBiotechnologyEcologyFood Science
2008English

Caged Protons as Tools for Studying Transport of Protons Along Lipid Bilayers

Biophysical Journal
Biophysics
2017English

The Role of GluN2A and GluN2B Subunits on the Effects of NMDA Receptor Antagonists in Modeling Schizophrenia and Treating Refractory Depression

Neuropsychopharmacology
PsychiatryMental HealthPharmacology
2014English

Repeated Spatial Acquisition: Effects of NMDA Antagonists and Morphine.

Experimental and Clinical Psychopharmacology
PsychiatryMental HealthPharmacology
2003English

In Silico Design, Synthesis and Pharmacological Screening of Quinazolinones as NMDA Receptor Antagonists for Anticonvulsant Activity: Part II

Journal of Young Pharmacists
ToxicologyPharmaceuticsPharmacology
2015English

Biopolymers for Neurotherapeutic Interventions

2016English

Experimental and Analytical Tools for Studying the Human Microbiome

Nature Reviews Genetics
GeneticsMolecular Biology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy